GlassScriptPhysician profile
Laurel A Kirkhart
NPI 1376583476
$420.57
in general payments reported to CMS, 2019-2025
12 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.62 · 2020: $45.30 · 2021: $59.32 · 2022: $32.27 · 2023: $55.91 · 2024: $60.30 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $217.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $86.56 | 2021-2025 | Nexplanon |
| Amgen INC. | $63.03 | 2019-2020 | |
| Pfizer INC. | $40.18 | 2019-2023 | |
| Abbvie INC. | $38.94 | 2019-2021 | |
| Novo Nordisk INC | $35.78 | 2022-2024 | Wegovy |
| Sumitomo Pharma America, INC. | $26.82 | 2024 | Myfembree |
| Sage Therapeutics, LLC | $25.25 | 2025 | Zurzuvae |
| Minerva Surgical, INC | $25.22 | 2019-2023 | |
| Astellas Pharma US INC | $23.39 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $20.26 | 2021 | |
| Conmed Corporation | $18.82 | 2025 | Airseal |
| Daiichi Sankyo INC. | $16.32 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laurel Kirkhart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.